Drug target · CHRM4
M4
Muscarinic acetylcholine receptor M4
4 compounds in the CNS pipeline act on M4.
Compounds targeting M4
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| Direclidine (NBI-1117568)primarySmall molecule | Agonist | — | Phase 3Schizophrenia | Neurocrine Biosciences, Inc. |
| Emraclidine (CVL-231)primarySmall molecule | PAM | — | Phase 2Schizophrenia | Cerevel Therapeutics Holdings, Inc. |
| NBI-1117570primarySmall molecule | Agonist | — | Phase 2Schizophrenia | Neurocrine Biosciences, Inc. |
| ML-007C-MASmall molecule | Agonist | EC50 830 nM | Phase 2Schizophrenia | MapLight Therapeutics, Inc. |